Structural Insight into Integrin Recognition and Anticancer Activity of Echistatin

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Echistatin (Ech) is a short disintegrin characterized by a long C-terminal tail.
• Disintegrins are known for their roles in cell adhesion and signaling.

Purpose of the Study:

• To determine the 3-D structure of Echistatin using X-ray crystallography.
• To investigate the role of Echistatin's C-terminal region in integrin inhibition and anticancer activity.

Main Methods:

• X-ray crystallography to elucidate Echistatin's 3-D structure.
• Integrin inhibition assays using various integrin subtypes (αvβ3, αIIbβ3, αvβ5, α5β1).
• Cell proliferation and migration assays to assess anticancer potential.

Main Results:

• Conformational differences were observed in the RGD loops and C-termini between Echistatin chains A and B.
• Truncation of the C-terminal tail significantly reduced integrin inhibition.
• Mutagenesis of specific C-terminal residues (H44A, K45A) modulated integrin binding affinity.
• Echistatin demonstrated potent inhibition of VEGF-induced HUVEC proliferation and tumor cell migration.

Conclusions:

• The C-terminal region of Echistatin plays a critical role in its integrin inhibitory functions.
• Echistatin exhibits significant anticancer properties, inhibiting both endothelial cell proliferation and tumor cell migration.
• Optimization of Echistatin's C-terminus holds promise for developing novel anticancer therapeutics.